fbpx
World Council of Optometry and CooperVision logos

WCO Issues Myopia Management Standard of Care Pledge Challenge

The World Council of Optometry (WCO), in partnership with myopia management category leader CooperVision, has issued a Myopia Management Standard of Care Pledge challenge. More than 35 global eye care organizations and 25,000 practitioners have so far pledged to adopt myopia management as the standard of care. 

 Learn more and take the pledge.

WCO President-elect Dr. Sandra Block said, “We challenge optometrists worldwide to adopt myopia management as the standard of care. Myopia has reached epidemic levels and we know that myopia can lead to eye health issues that reveal themselves in adults.  It is our hope that early diagnosis of myopia and management can help reduce the long-term eye health complications.  Taking the pledge sends a clear message that organizations and practitioners understand the seriousness of myopia as a public health threat and that they are taking active measures to manage that threat.”

The World Council of Optometry and CooperVision introduced the myopia management standard of care resolution in April 2021, defining an evidence-based standard of care comprised of three main components:

  • Mitigation — Optometrists educating and counseling parents and children, during early and regular eye exams, on lifestyle, dietary, and other factors to prevent or delay the onset of myopia.
  • Measurement — Optometrists evaluating the status of a patient during regular comprehensive vision and eye health exams, such as measuring refractive error and axial length whenever possible.
  • Management — Optometrists addressing patients’ needs of today by correcting myopia, while also providing evidence-based interventions that slow the progression of myopia, for improved quality of life and better eye health today and into the future.   

The World Council of Optometry has a myopia management online resource featuring the standard of care resolution, pledge signup page, and practical tools and information for optometrists available at https://myopia.worldcouncilofoptometry.info/.

Click HERE for the full press release.

Featured Posts

Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more